Bioorganic and Medicinal Chemistry Letters p. 2099 - 2104 (1997)
Update date:2022-08-04
Topics:
Asari, Tohru
Ishikawa, Shigetaka
Sasaki, Toshiki
Katada, Jun
Hayashi, Yoshio
Harada, Takeo
Yano, Mako
Yasuda, Emiko
Uno, Isao
Ojima, Iwao
The synthetic and structure-activity relationship (SAR) studies of new non-peptide GPIIb/IIIa antagonists (1a-f and 3) were conducted by replacing one amide bond of NSL-95300 (2) with an (E)-double bond or an enone group. NSL-95315 (1a) and NSL-95317 (3) showed the inhibitory activity for collagen-induced human platelet aggregation with IC50 values of 0.25 μM and 0.21 μM, respectively.
View Morewebsite:http://www.tbbmed.com
Contact:86--21-50498136
Address:Room 6002, Building 7-1, No.160 Basheng Road,Pudong Area,Shanghai China
Jinan YouCheng Pharmatech Co.,Ltd
Contact:+86-18653163205
Address:No.750, Shunhua Road, University Science Park, High-tech Zone, Jinan City
Chemieliva Pharmaceutical Co., Ltd.
website:http://www.chemieliva.com
Contact:+86-23-67770219
Address:99 Longhua Road, Yubei District, 401147, Chongqing, China Email: sales@chemieliva.com Tel:0086-23-67770219 Fax: 0086-23-67770220 Attn: Andy Huang
Contact:+86-20-38011066
Address:3510, Diwang Commercial Center, 5002 Shennan Rd, Shenzhen, P.R.China
website:http://www.afinechem.com
Contact:+86-571-85134551
Address:No. 206 Zhen Hua Road, Hangzhou 310030, Zhejiang, China
Doi:10.1016/S0031-9422(97)00116-7
(1997)Doi:10.1016/S0960-894X(02)01070-3
(2003)Doi:10.1055/s-1997-1524
(1997)Doi:10.1016/S0020-1693(97)05694-6
(1997)Doi:10.1007/s11172-017-1764-1
(2017)Doi:10.1039/a703112b
(1997)
